FDA Orange Book · active-ingredient family
Floxuridine
Floxuridine is approved as 1 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:FUDR · NDA 016929
1
Brand (NDA)
3
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| FUDRRLD | HOSPIRA | NDA 016929 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (3)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| FLOXURIDINE | AM REGENT | ANDA 203008 | — | Nov 22, 2017 | |
| FLOXURIDINE | FRESENIUS KABI USA | ANDA 075837 | AP | Feb 22, 2001 | |
| FLOXURIDINE | HIKMA | ANDA 075387 | AP | Apr 16, 2000 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Floxuridine — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

